Magnesium intake and risk of colorectal cancer: A meta-analysis of prospective studies

European Journal of Clinical Nutrition

Volumn 66, Issue 11, 2012, Pages 1182-1186

  Chen, G C ^a   Pang, Z ^b   Liu, Q F ^a  

^a SOOCHOW UNIVERSITY   (China)

^b SUZHOU MUNICIPAL HOSPITAL   (China)

Author keywords

colorectal cancer; magnesium; meta analysis; prospective studies

Indexed keywords

MAGNESIUM;

ADULT; AGE; AGED; BODY MASS; CALORIC INTAKE; CANCER RISK; CLINICAL EFFECTIVENESS; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DIETARY FIBER; DIETARY INTAKE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PHYSICAL ACTIVITY; RECTUM CANCER; REVIEW; RISK REDUCTION; VITAMIN INTAKE;

ANIMALS; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DIET; ENERGY INTAKE; HUMANS; MAGNESIUM; RECTAL NEOPLASMS; RISK; TRACE ELEMENTS;

EID: 84868640186     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2012.135     Document Type: Review

References (39)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-592.
2. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-236.
3. Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, Bandera EV et al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2012; 62: 30-67.
4. Platz EA, Willett WC, Colditz GA, Rimm EB, Spiegelman D, Giovannucci E. Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes Control 2000; 11: 579-588.
5. Wolf FI, Trapani V. Cell (patho)physiology of magnesium. Clin Sci (Lond) 2008; 114: 27-35.
6. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta 2000; 294: 1-26.
7. Hartwig A. Role of magnesium in genomic stability. Mutat Res 2001; 475: 113-121.
8. Mori H, Morishita Y, Mori Y, Yoshimi N, Sugie S, Tanaka T. Effect of magnesium hydroxide on methylazoxymethanol acetate-induced epithelial proliferation in the large bowels of rats. Cancer Lett 1992; 62: 43-48.
9. Mori H, Morishita Y, Shinoda T, Tanaka T. Preventive effect of magnesium hydroxide on carcinogen-induced large bowel carcinogenesis in rats. Basic Life Sci 1993; 61: 111-118.
10. Wang A, Yoshimi N, Tanaka T, Mori H. Inhibitory effects of magnesium hydroxide on c-myc expression and cell proliferation induced by methylazoxymethanol acetate in rat colon. Cancer Lett 1993; 75: 73-78.
11. Wang A, Yoshimi N, Tanaka T, Mori H. The inhibitory effect of magnesium hydroxide on the bile acid-induced cell proliferation of colon epithelium in rats with comparison to the action of calcium lactate. Carcinogenesis 1994; 15: 2661-2663.
12. Dong JY, Xun P, He K, Qin LQ. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care 2011; 34: 2116-2122.
13. Luo J, Chlebowski R, Liu S, McGlynn KA, Parekh N, White DL et al. Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women. Cancer Causes Control 2012; 23: 1599-1605.
14. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA et al. Diabetes and cancer: a consensus report. CA Cancer J Clin 2010; 60: 207-221.
15. Hartz A, He T, Ross JJ. Risk factors for colon cancer in 150,912 postmenopausal women. Cancer Causes Control 2012; e-pub ahead of print 2 August 2012.
16. Chacko SA, Sul J, Song Y, Li X, LeBlanc J, You Y et al. Magnesium supplementation, metabolic and inflammatory markers, and global genomic and proteomic profiling: a randomized, double-blind, controlled, crossover trial in overweight individuals. Am J Clin Nutr 2011; 93: 463-473.
17. Wu K, Feskanich D, Fuchs CS, Chan AT, Willett WC, Hollis BW et al. Interactions between plasma levels of 25-hydroxyvitamin D, insulin-like growth factor (IGF)-1 and C-peptide with risk of colorectal cancer. PLoS One 2011; 6: e28520.
18. Pisani P. Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem 2008; 114: 63-70.
19. Larsson SC, Bergkvist L, Wolk A. Magnesium intake in relation to risk of colorectal cancer in women. JAMA 2005; 293: 86-89.
20. Folsom AR, Hong CP. Magnesium intake and reduced risk of colon cancer in a prospective study of women. Am J Epidemiol 2006; 163: 232-235.
21. Lin J, Cook NR, Lee IM, Manson JE, Buring JE, Zhang SM. Total magnesium intake and colorectal cancer incidence in women. Cancer Epidemiol Biomarkers Prev 2006; 15: 2006-2009.
22. van den Brandt PA, Smits KM, Goldbohm RA, Weijenberg MP. Magnesium intake and colorectal cancer risk in the Netherlands Cohort Study. Br J Cancer 2007; 96: 510-513.
23. Ma E, Sasazuki S, Inoue M, Iwasaki M, Sawada N, Takachi R et al. High dietary intake of magnesium may decrease risk of colorectal cancer in Japanese men. J Nutr 2010; 140: 779-785.
24. Li K, Kaaks R, Linseisen J, Rohrmann S. Dietary calcium and magnesium intake in relation to cancer incidence and mortality in a German prospective cohort (EPICHeidelberg). Cancer Causes Control 2011; 22: 1375-1382.
25. Key TJ, Appleby PN, Masset G, Brunner EJ, Cade JE, Greenwood DC et al. Vitamins, minerals, essential fatty acids and colorectal cancer risk in the United Kingdom Dietary Cohort Consortium. Int J Cancer 2011; e-pub ahead of print 3 December 2011; 131: E320-E325.
26. Zhang X, Giovannucci EL, Wu K, Smith-Warner SA, Fuchs CS, Pollak M et al. Magnesium intake, plasma C-peptide, and colorectal cancer incidence in US women: a 28-year follow-up study. Br J Cancer 2012; 106: 1335-1341.
27. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al. Metaanalysis of observational studies in epidemiology: a proposal for reporting. Metaanalysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
28. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
29. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992; 135: 1301-1309.
30. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-respose data. Stata J 2006; 6: 40-57.
31. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
32. Egger M, Davey Smith G, Schneider M. Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
33. Norman DA, Fordtran JS, Brinkley LJ, Zerwekh JE, Nicar MJ, Strowig SM et al. Jejunal and ileal adaptation to alterations in dietary calcium: changes in calcium and magnesium absorption and pathogenetic role of parathyroid hormone and 1,25-dihydroxyvitamin D. J Clin Invest 1981; 67: 1599-1603.
34. Macquart-Moulin G, Riboli E, Cornee J, Charnay B, Berthezene P, Day N. Casecontrol study on colorectal cancer and diet in Marseilles. Int J Cancer 1986; 38: 183-191.
35. Tuyns AJ, Haelterman M, Kaaks R. Colorectal cancer and the intake of nutrients: oligosaccharides are a risk factor, fats are not. A case-control study in Belgium. Nutr Cancer 1987; 10: 181-196.
36. Benito E, Stiggelbout A, Bosch FX, Obrador A, Kaldor J, Mulet M et al. Nutritional factors in colorectal cancer risk: a case-control study in Majorca. Int J Cancer 1991; 49: 161-167.
37. Zaridze DG, Filipchenko VV. [The role of nutrition in the etiology of cancer of the large intestine]. Vopr Onkol 1991; 37: 152-158.
38. Dai Q, Shrubsole MJ, Ness RM, Schlundt D, Cai Q, Smalley WE et al. The relation of magnesium and calcium intakes and a genetic polymorphism in the magnesium transporter to colorectal neoplasia risk. Am J Clin Nutr 2007; 86: 743-751.
39. Wiklund L, Pousette J, George M. Magnesium intake, drinking water, and risk of colorectal cancer. JAMA 2005; 293: 2599; author reply.